Diabetes Self-Management Articles

These articles cover a wide range of subjects, from the most basic aspects of diabetes care to the nitty-gritty specifics.

Links not loading properly?

Some of our pages use Portable Document Format (PDF) files, which require Adobe Acrobat Reader. To download Acrobat Reader for free, visit www.adobe.com.

Sign up for our weekly e-mail newsletter and receive a FREE GIFT! Enter your e-mail below.

Learn more

Learn more about diabetes

Links to help you learn more about diabetes.

Ask a diabetes expert
Other diabetes resources
Browse article topics


Second-Phase Insulin Injection

A prolonged phase of insulin secretion by the pancreas in response to glucose entering the bloodstream.

Researchers have identified two distinct phases of insulin secretion by the pancreas that occur when study subjects are given an intravenous glucose injection. The first phase occurs within the first few minutes after the glucose injection, when the blood glucose level abruptly rises. That phase of insulin release, which subsides after about 10–15 minutes, is thought to involve the release of insulin already stored within the beta cells. The first phase is followed by a second phase of insulin release, which is more prolonged.

Researchers think that similar phases occur in response to carbohydrate that is ingested, rather than injected. They speculate that the early stage of insulin secretion is very important for proper glucose metabolism, and that when it goes awry, it may set the stage for impaired glucose tolerance and Type 2 diabetes. When the early-stage insulin secretion is diminished, blood glucose levels tend to rise significantly right after meals. The pancreas compensates for this rise by increasing the second-phase insulin secretion, which eventually brings blood glucose levels back to normal. However, these high levels of glucose and insulin in the bloodstream may damage the beta cells and further impair their ability to function. The chronically high levels of insulin can also play a role in increased insulin resistance, contributing to chronic high blood glucose and full-blown Type 2 diabetes.

Different types of medicines for Type 2 diabetes lower blood glucose levels in different ways. Sulfonylureas such as glimepiride (brand name Amaryl), glyburide (Diabeta, Glynase, Micronase), and glipizide (Glucotrol, Glucotrol XL) increase both first-phase and second-phase insulin secretion. The drugs repaglinide (Prandin) and nateglinide (Starlix), which stimulate the pancreas to release more insulin just after meals, and the injectable drugs exenatide (Byetta, Bydureon) and liraglutide (Victoza) have a greater effect on early-stage insulin secretion. Some researchers speculate that intensively treating the early-stage insulin secretion may slow the progression of Type 2 diabetes early in the course of the disease.



More articles on Diabetes Definitions



Statements and opinions expressed on this Web site are those of the authors and not necessarily those of the publishers or advertisers. The information provided on this Web site should not be construed as medical instruction. Consult appropriate health-care professionals before taking action based on this information.



Learning About the Insulin Response
All most people know about insulin is that it has something to do with sugar and diabetes.... Blog

Batman has Robin. The Lone Ranger has Tonto. And insulin has its own tough little partner:... Article

New Tools 2008
The management of diabetes requires a certain amount of paraphernalia: A meter, lancing device,... Article

I'm feeling fine. Do I still have to keep an eye on my blood glucose levels? Get tip